Guilin Sanjin Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guilin Sanjin Pharmaceutical Co Ltd with three other
companies in this sector in China:
Guangxi Wuzhou Zhongheng Group, Ltd.
sales of 1.34 billion Chinese Renmimbi [US$194.84 million]
of which 91%
was Pharmaceutical Segment),
Xiangxue Pharmaceutical Co Ltd
(1.46 billion Chinese Renmimbi [US$212.60 million]
of which 53%
was Pharmaceutical Manufacturing), and
Shanghai Kaibao Pharmaceutical Company Limited
(1.40 billion Chinese Renmimbi [US$202.73 million]
of which 100%
Guilin Sanjin Pharmaceutical Co Ltd reported sales of 1.37 billion Chinese Renmimbi (US$199.27 million)
December of 2015.
decrease of 6.4%
versus 2014, when the company's sales were 1.47 billion Chinese Renmimbi.